Today: 22 July 2026
SoFi stock slips in premarket as inflation data looms — what investors are watching next
27 February 2026
1 min read

SoFi stock slips in premarket as inflation data looms — what investors are watching next

New York, February 27, 2026, 07:15 EST — Premarket

  • SoFi shares dipped roughly 2% before the bell, adding to Thursday’s 1% decline.
  • Risk appetite remained wobbly going into U.S. producer-price figures, following a fresh round of wild swings in tech stocks.
  • Next up: inflation numbers and where rates might go from here. SoFi’s earnings land in early May.

SoFi Technologies Inc (SOFI.O) slipped roughly 2% in Friday’s premarket, changing hands at $18.72. The day before, shares closed at $19.10, down 1% after a 3.4% pop on Wednesday.

U.S. stock index futures slipped, with traders eyeing upcoming producer-price numbers—a key inflation readout for manufacturers. Markets have been skittish: Block jumped almost 19% following its announcement to slash thousands of jobs and shift toward AI.

Rates remain in flux. The benchmark U.S. 10-year Treasury yield edged down to roughly 3.99%, leaving rate-sensitive stocks constrained as traders looked ahead to the day’s data.

SoFi delivers digital finance services with a member-first approach, spanning lending, banking, and investing, and also provides tech solutions to fellow financial firms. The company breaks out its results in three buckets: Lending, Technology Platform, and Financial Services.

The stock’s had a pronounced high-growth bias, lurching as risk appetite waxes and investors recalibrate their views on the destination for interest rates.

Back on Jan. 30, the company delivered its last big spark: fourth-quarter profit surged, thanks to robust loan demand and a sharp pickup in fee-based business. Revenue tied to financial services jumped 78% to $456.7 million, and loan originations reached a record $10.5 billion, according to Reuters. CEO Anthony Noto pointed out that credit performance met expectations, adding that members’ financial health “remained strong.” Reuters

Much of the trading lately has boiled down to sentiment, analysts say. Citizens analyst Devin Ryan, in a Feb. 9 note, put it this way: “the market’s recent risk-off rotation has penalized higher-growth/’speculative-adjacent’ narratives.” Ryan upgraded the stock, targeting $30. (Risk-off means moving out of riskier growth names.) Investing.com

Risks aren’t one-sided here. If the economy weakens, loan growth may lose steam and delinquencies could tick up. And when policy shifts hit consumer credit, lenders and fintechs often have to scramble to reprice risk on the fly.

Traders are bracing for producer-price figures set to drop ahead of the opening bell, watching for any ripple effect on Treasury yields next session.

SoFi’s next earnings report lands May 4, according to Investing.com.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Alphabet Q2 2026: Google Cloud Powers Majority of Profit Gains, Free Cash Flow Slides Into Negative
    July 22, 2026, 4:57 PM EDT. Google Cloud posted an 82% jump in revenue to $24.8 billion for Alphabet in Q2, accounting for 63% of operating profit growth and achieving a 35.6% margin. Overall revenue climbed 24% to $119.8 billion, topping analysts' projections. Despite this, free cash flow was negative at $5.9 billion as capital expenditures outpaced operating cash flow by 115%. No share repurchases took place during the quarter.
Intel stock slides as chip rally cools — what’s driving INTC today
Previous Story

Intel stock slides as chip rally cools — what’s driving INTC today

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears
Next Story

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Go toTop